PH27608A - Polyamines useful as antagonists of excitatory amino acid neurotransmitters - Google Patents

Polyamines useful as antagonists of excitatory amino acid neurotransmitters

Info

Publication number
PH27608A
PH27608A PH41752A PH41752A PH27608A PH 27608 A PH27608 A PH 27608A PH 41752 A PH41752 A PH 41752A PH 41752 A PH41752 A PH 41752A PH 27608 A PH27608 A PH 27608A
Authority
PH
Philippines
Prior art keywords
amino acid
excitatory amino
neurotransmitters
antagonists
polyamines useful
Prior art date
Application number
PH41752A
Other languages
English (en)
Inventor
Nicholas Alex Saccomano
Robert Alredo Vaokmann
Original Assignee
Pfizer
Natural Product Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Natural Product Sciences Inc filed Critical Pfizer
Publication of PH27608A publication Critical patent/PH27608A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyamides (AREA)
  • Indole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PH41752A 1990-01-02 1990-12-19 Polyamines useful as antagonists of excitatory amino acid neurotransmitters PH27608A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46020790A 1990-01-02 1990-01-02
US07/560,699 US5037846A (en) 1990-01-02 1990-07-31 Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters

Publications (1)

Publication Number Publication Date
PH27608A true PH27608A (en) 1993-08-18

Family

ID=27039601

Family Applications (1)

Application Number Title Priority Date Filing Date
PH41752A PH27608A (en) 1990-01-02 1990-12-19 Polyamines useful as antagonists of excitatory amino acid neurotransmitters

Country Status (23)

Country Link
US (1) US5037846A (ko)
EP (1) EP0436332B1 (ko)
JP (1) JPH0714913B2 (ko)
KR (1) KR930007250B1 (ko)
CN (1) CN1053059A (ko)
AT (1) ATE133941T1 (ko)
AU (2) AU619700B2 (ko)
CA (1) CA2033480C (ko)
DE (1) DE69025305T2 (ko)
DK (1) DK0436332T3 (ko)
ES (1) ES2083439T3 (ko)
FI (1) FI93644C (ko)
GR (1) GR3019487T3 (ko)
HU (1) HUT56063A (ko)
IE (1) IE70757B1 (ko)
IL (1) IL96793A0 (ko)
MY (1) MY104588A (ko)
NO (1) NO173733C (ko)
NZ (1) NZ236550A (ko)
PH (1) PH27608A (ko)
PL (1) PL165647B1 (ko)
PT (1) PT96389A (ko)
YU (1) YU247590A (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227397A (en) * 1989-04-28 1993-07-13 Pfizer Inc. Polyamines and polypeptides useful as antagonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels
US5037846A (en) * 1990-01-02 1991-08-06 Pfizer Inc. Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters
US5312928A (en) * 1991-02-11 1994-05-17 Cambridge Neuroscience Calcium channel antagonists and methodology for their identification
US5677288A (en) * 1991-05-15 1997-10-14 Cypros Pharmaceutical Corporation Use of aminoglycosides to protect against excitotoxic neuron damage
US5185369A (en) * 1991-08-23 1993-02-09 Pfizer Inc. Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists
HU9400503D0 (en) * 1991-08-23 1994-05-30 Pfizer Synthetic aryl polyamines as excitatory amino acid neurotransmitter antagonists
US5763568A (en) * 1992-01-31 1998-06-09 Zeneca Limited Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
US6750244B2 (en) 1993-02-08 2004-06-15 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6017965A (en) * 1993-02-08 2000-01-25 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6211245B1 (en) 1993-02-08 2001-04-03 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6071970A (en) * 1993-02-08 2000-06-06 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US7087765B2 (en) 1995-06-07 2006-08-08 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
EP1749522A3 (en) * 1994-02-08 2010-10-27 NPS Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US5874298A (en) * 1995-02-17 1999-02-23 Nps Pharmaceuticals, Inc. Insecticidal toxins from Bracon hebetor nucleic acid encoding said toxin and methods of use
US5688764A (en) * 1995-02-17 1997-11-18 Nps Pharmaceuticals, Inc. Insecticidal peptides from spider venom
US5674846A (en) * 1996-09-04 1997-10-07 Nps Pharmaceuticals, Inc. Insecticidal peptides from Segestria sp. spider venom
US6063819A (en) * 1997-02-21 2000-05-16 Cypros Pharmaceutical Corp. Neuroprotective poly-guanidino compounds which block presynaptic N and P/Q calcium channels
US7087648B1 (en) * 1997-10-27 2006-08-08 The Regents Of The University Of California Methods for modulating macrophage proliferation using polyamine analogs
US8198334B2 (en) * 1997-10-27 2012-06-12 Pathologica Llc Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
AU2003231670B2 (en) * 1997-10-27 2006-06-08 Slil Biomedical Corporation Methods for modulating macrophage proliferation using polyamine analogs
US7030126B2 (en) 2001-11-16 2006-04-18 Als Therapy Development Foundation, Inc. Use of polyamine analogs for amyotrophic lateral sclerosis
EP1448183A2 (en) * 2001-11-16 2004-08-25 ALS Therapy Development Foundation, Inc. Treatment of neurodegenerative disorders through the modulation of the polyamine pathway
EP1799200A1 (en) * 2004-10-04 2007-06-27 Cellgate, Inc. Polyamine analogs as therapeutic agents for ocular diseases
WO2007035957A2 (en) * 2005-09-23 2007-03-29 Pathologica, Llc. Methods for treating viral infections using polyamine analogs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925664A (en) * 1986-10-20 1990-05-15 University Of Utah Spider toxins and methods for their use as blockers of calcium channels and amino acid receptor function
IT1206078B (it) * 1987-06-03 1989-04-14 Polifarma Spa Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico
US4950739A (en) * 1988-02-10 1990-08-21 New York University Membrane calcium channels and factors and methods for blocking, isolating and purifying calcium channels
DD298412A5 (de) * 1989-04-28 1992-02-20 ������@���Kk�� Verfahren zur herstellung von polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele
US5037846A (en) * 1990-01-02 1991-08-06 Pfizer Inc. Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters

Also Published As

Publication number Publication date
DE69025305T2 (de) 1996-06-27
IL96793A0 (en) 1991-09-16
IE70757B1 (en) 1996-12-30
FI906466A (fi) 1991-07-03
GR3019487T3 (en) 1996-07-31
JPH04210677A (ja) 1992-07-31
DK0436332T3 (da) 1996-03-11
FI93644C (fi) 1995-05-10
DE69025305D1 (de) 1996-03-21
CA2033480A1 (en) 1991-07-03
CA2033480C (en) 1995-11-21
NZ236550A (en) 1992-05-26
ES2083439T3 (es) 1996-04-16
NO173733B (no) 1993-10-18
AU1592692A (en) 1992-07-09
ATE133941T1 (de) 1996-02-15
FI906466A0 (fi) 1990-12-31
AU640565B2 (en) 1993-08-26
EP0436332B1 (en) 1996-02-07
JPH0714913B2 (ja) 1995-02-22
FI93644B (fi) 1995-01-31
MY104588A (en) 1994-04-30
PT96389A (pt) 1991-10-15
AU6856190A (en) 1991-07-04
HUT56063A (en) 1991-07-29
KR910014123A (ko) 1991-08-31
YU247590A (sh) 1993-10-20
US5037846A (en) 1991-08-06
AU619700B2 (en) 1992-01-30
EP0436332A2 (en) 1991-07-10
NO173733C (no) 1994-01-26
PL165647B1 (pl) 1995-01-31
KR930007250B1 (ko) 1993-08-04
CN1053059A (zh) 1991-07-17
EP0436332A3 (en) 1991-09-25
NO905616L (no) 1991-07-03
IE904734A1 (en) 1991-07-17
NO905616D0 (no) 1990-12-28
PL288490A1 (en) 1991-12-16

Similar Documents

Publication Publication Date Title
GR3019487T3 (en) Polyamines useful as antagonists of excitatory amino acid neurotransmitters
CA2194103A1 (en) Polypeptides Useful as Calcium Channel Blockers
FI112471B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten hydroksietyyliaminosulfoniamidien valmistamiseksi
HUT46708A (en) Process for producing heterocyclic ketones and pharmaceutical compositions containing them as active components
OA09982A (fr) Derives heterocycliques leur procede de production et composition pharmaceutique les contenant
AU621483B2 (en) Azaindenes
AU6320394A (en) Aryl substituted heterocycles
NO20001764L (no) FremgangsmÕte for fremstilling av melkesyre, og syretolerant homolaktisk bakterie
ATE82327T1 (de) Neues herbizid, seine herstellung und seine verwendung.
HU906267D0 (en) Process for the production of polypeptides blocking the calcium channel
DE60200535D1 (de) Verfahren zur Herstellung von hoch reinem Pemirolast
FI893682A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi
DE69503093T2 (de) Verfahren zur Herstellung von Guaniden